Gaia Cusumano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gaia Cusumano has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Giancarlo Angeles Flores
Department of Chemistry, Biology and Biotechnology University of Perugia Perugia Italy
11 shared publications - Paola Angelini
Department of Chemistry, Biology and Biotechnology University of Perugia Perugia Italy
11 shared publications - Carla Emiliani
Department of Chemistry, Biology and Biotechnology, University of Perugia, Via del Giochetto, 06123 Perugia, Italy
9 shared publications - Gokhan Zengin
Department of Biology, Science Faculty, Selcuk University, Konya, Turkey
8 shared publications - Roberto Venanzoni
University of Perugia
8 shared publications - Agnese Bertoldi
Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy
7 shared publications
Latest Publications
- Open Access
- 24 April 2026
- Published by MDPI AG in Nutraceuticals
- Vol. 6 (2) , 27
Correction: Di Simone et al. Unravelling the Neuroprotective Effects of a Novel Formulation Based on Plant Extracts, Mg, and Vitamin B6. Nutraceuticals 2025, 5, 5
- 24 April 2026
- Published by MDPI AG in Nutraceuticals
- Vol. 6 (2) , 27
Open AccessCorrection: Di Simone et al. Unravelling the Neuroprotective Effects of a Novel Formulation Based on Plant Extracts, Mg, and Vitamin B6. Nutraceuticals 2025, 5, 5
- Open Access
- 22 April 2026
- Published by Springer Nature in Research Square
Interconnected Environmental Risks in the Anthropocene: A Systems-Based Review of Drivers, Feedbacks, and Governance
In the Anthropocene, environmental risks are increasingly interconnected, forming complex systems characterized by feedback loops, cascading effects, and cross-scale interactions. This study presents a structured interdisciplinary review of twelve major environmental domains, examining how climate change, biodiversity loss, pollution, resource depletion, and environmental injustice interact within a tightly coupled Earth system. A systematic literature review was conducted across major scientific databases and complemented by key institutional reports, resulting in a dataset of 218 sources analyzed through qualitative thematic coding. The analysis identifies shared structural drivers—including unsustainable production and consumption patterns, technological development trajectories, and governance fragmentation—that generate and amplify systemic environmental risks. The findings show that environmental challenges are not isolated phenomena but interconnected components of a dynamic system in which impacts propagate across domains, reinforcing vulnerability and accelerating the transgression of planetary boundaries. By integrating biophysical processes with governance structures and environmental justice considerations, this study develops a systems-oriented conceptual framework that highlights feedback mechanisms and identifies potential leverage points for intervention. The results underscore the need for integrated, adaptive, and equitable governance strategies capable of addressing interconnected environmental risks. Advancing sustainability in the Anthropocene requires moving beyond fragmented approaches toward systemic and transformative responses that align ecological limits with socio-economic systems.
- 22 April 2026
- Published by Springer Nature in Research Square
Open AccessInterconnected Environmental Risks in the Anthropocene: A Systems-Based Review of Drivers, Feedbacks, and Governance
In the Anthropocene, environmental risks are increasingly interconnected, forming complex systems characterized by feedback loops, cascading effects, and cross-scale interactions. This study presents a structured interdisciplinary review of twelve major environmental domains, examining how climate change, biodiversity loss, pollution, resource depletion, and environmental injustice interact within a tightly coupled Earth system. A systematic literature review was conducted across major scientific databases and complemented by key institutional reports, resulting in a dataset of 218 sources analyzed through qualitative thematic coding. The analysis identifies shared structural drivers—including unsustainable production and consumption patterns, technological development trajectories, and governance fragmentation—that generate and amplify systemic environmental risks. The findings show that environmental challenges are not isolated phenomena but interconnected components of a dynamic system in which impacts propagate across domains, reinforcing vulnerability and accelerating the transgression of planetary boundaries. By integrating biophysical processes with governance structures and environmental justice considerations, this study develops a systems-oriented conceptual framework that highlights feedback mechanisms and identifies potential leverage points for intervention. The results underscore the need for integrated, adaptive, and equitable governance strategies capable of addressing interconnected environmental risks. Advancing sustainability in the Anthropocene requires moving beyond fragmented approaches toward systemic and transformative responses that align ecological limits with socio-economic systems.
- Open Access
- 8 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (20) , 18636-18656
Harnessing the anti-inflammatory, skin-protective, and antioxidant potential of Epilobium dodonaei extracts using in vitro and in silico approaches
Epilobium dodonaei can be considered as a potential raw material for health-promoting applications.
- 8 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (20) , 18636-18656
Open AccessHarnessing the anti-inflammatory, skin-protective, and antioxidant potential of Epilobium dodonaei extracts using in vitro and in silico approaches
Epilobium dodonaei can be considered as a potential raw material for health-promoting applications.
- Open Access
- 25 March 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (7) , 394
Extracellular Vesicles from Capparis spinosa Modulate Epithelial-to-Mesenchymal Transition in Huh7 Hepatocellular Carcinoma Cells
Background: Epithelial-to-mesenchymal transition (EMT) is a cellular reprogramming process characterized by coordinated changes in signaling, membrane organization and metabolism. In a previously established and deeply characterized Huh7 EMT model, it was demonstrated that TGF-β stimulation induces a reproducible shift toward a mesenchymal state accompanied by lipidomic and metabolic remodeling. Building on this framework, the present study evaluates whether extracellular vesicles (EVs)-enriched fractions derived from Capparis spinosa can modulate these EMT-associated alterations. Methods: After detailed physicochemical, molecular, lipidomic and metabolomic characterization, C. spinosa EVs were applied to EMT-induced Huh7 cells. The vesicles were efficiently internalized and, while not inducing a complete epithelial reversion, they attenuated mesenchymal features, indicating a modulatory rather than inhibitory action. Results: Lipidomic profiling showed a partial correction of TGF-β-induced changes including diacylglycerols, phosphoinositides and triglycerides, suggesting interference with lipid signaling and membrane turnover. Metabolomic data further points to reduced mitochondrial and fatty acid oxidation stress, reflected in the re-equilibration of carnitine and acylcarnitine species. Conclusions: Together, these findings indicate that C. spinosa EVs are able to attenuate EMT-associated metabolic and membrane remodeling, positioning them as promising modulators of tumor cell plasticity.
- 25 March 2026
- Published by MDPI AG in Nanomaterials
- Vol. 16 (7) , 394
Open AccessExtracellular Vesicles from Capparis spinosa Modulate Epithelial-to-Mesenchymal Transition in Huh7 Hepatocellular Carcinoma Cells
Background: Epithelial-to-mesenchymal transition (EMT) is a cellular reprogramming process characterized by coordinated changes in signaling, membrane organization and metabolism. In a previously established and deeply characterized Huh7 EMT model, it was demonstrated that TGF-β stimulation induces a reproducible shift toward a mesenchymal state accompanied by lipidomic and metabolic remodeling. Building on this framework, the present study evaluates whether extracellular vesicles (EVs)-enriched fractions derived from Capparis spinosa can modulate these EMT-associated alterations. Methods: After detailed physicochemical, molecular, lipidomic and metabolomic characterization, C. spinosa EVs were applied to EMT-induced Huh7 cells. The vesicles were efficiently internalized and, while not inducing a complete epithelial reversion, they attenuated mesenchymal features, indicating a modulatory rather than inhibitory action. Results: Lipidomic profiling showed a partial correction of TGF-β-induced changes including diacylglycerols, phosphoinositides and triglycerides, suggesting interference with lipid signaling and membrane turnover. Metabolomic data further points to reduced mitochondrial and fatty acid oxidation stress, reflected in the re-equilibration of carnitine and acylcarnitine species. Conclusions: Together, these findings indicate that C. spinosa EVs are able to attenuate EMT-associated metabolic and membrane remodeling, positioning them as promising modulators of tumor cell plasticity.
- Open Access
Biodiversity-Driven Natural Products and Bioactive Metabolites
Natural products represent one of the most diverse and functionally sophisticated groups of bioactive molecules found across plants, fungi, bacteria, and marine organisms. Recent advances in genomics, metabolomics, and chemical ecology have fundamentally redefined how these compounds are generated, regulated, and functionally deployed in nature. Increasing evidence reveals that chemical diversity arises not solely from taxonomic lineage but from ecological pressures, evolutionary innovation, and multi-organism interactions that shape biosynthetic pathways over time. Hybrid metabolic architectures, context-dependent activation of biosynthetic gene clusters, and cross-kingdom metabolic integration collectively portray a biosynthetic landscape far more dynamic and interconnected than previously understood. At the same time, mechanistic studies demonstrate that natural products rarely act through single-target interactions. Instead, they influence redox dynamics, membrane architecture, chromatin accessibility, and intracellular signaling in distributed and synergistic ways that reflect both ecological function and evolutionary design. This review synthesizes emerging insights into the evolutionary drivers, ecological determinants, and mechanistic foundations of natural product diversity, highlighting the central role of silent biosynthetic gene clusters, meta-organismal chemistry, and network-level modes of action. By integrating these perspectives, we outline a conceptual and methodological framework capable of unlocking the vast biosynthetic potential that remains dormant within natural systems. Collectively, these advances reposition natural product research as a deeply integrative discipline at the intersection of molecular biology, ecology, evolution, and chemical innovation.
Open AccessBiodiversity-Driven Natural Products and Bioactive Metabolites
Natural products represent one of the most diverse and functionally sophisticated groups of bioactive molecules found across plants, fungi, bacteria, and marine organisms. Recent advances in genomics, metabolomics, and chemical ecology have fundamentally redefined how these compounds are generated, regulated, and functionally deployed in nature. Increasing evidence reveals that chemical diversity arises not solely from taxonomic lineage but from ecological pressures, evolutionary innovation, and multi-organism interactions that shape biosynthetic pathways over time. Hybrid metabolic architectures, context-dependent activation of biosynthetic gene clusters, and cross-kingdom metabolic integration collectively portray a biosynthetic landscape far more dynamic and interconnected than previously understood. At the same time, mechanistic studies demonstrate that natural products rarely act through single-target interactions. Instead, they influence redox dynamics, membrane architecture, chromatin accessibility, and intracellular signaling in distributed and synergistic ways that reflect both ecological function and evolutionary design. This review synthesizes emerging insights into the evolutionary drivers, ecological determinants, and mechanistic foundations of natural product diversity, highlighting the central role of silent biosynthetic gene clusters, meta-organismal chemistry, and network-level modes of action. By integrating these perspectives, we outline a conceptual and methodological framework capable of unlocking the vast biosynthetic potential that remains dormant within natural systems. Collectively, these advances reposition natural product research as a deeply integrative discipline at the intersection of molecular biology, ecology, evolution, and chemical innovation.
- Open Access
Rhubarb-Derived Extracellular Vesicles Mitigate Oxidative Stress and Metabolic Dysfunction in an Alzheimer’s Cellular Model
Background/Objectives: Extracellular vesicles derived from edible plants have emerged as bioactive nanostructures with potential therapeutic and nutraceutical properties and are currently being investigated as natural carriers for the treatment of oxidative stress-induced damage and oxidative stress-related diseases, including neurodegenerative disorders such as Alzheimer’s disease (AD). Recent studies suggest that PDEVs exhibit high stability within the gastrointestinal tract and selective tissue-targeting abilities, facilitating the efficient delivery of bioactive molecules. Methods: This study investigates the antioxidant effects of Rheum rhabarbarum-derived EVs by assessing the antioxidant activity through different in vitro assays and their effects on oxidative stress and energy metabolism in the cellular model of Alzheimer’s disease. Results: Rhubarb-derived EVs showed measurable antioxidant capacity in chemical assays and were non-toxic under the tested conditions. Treatment reduced intracellular ROS levels and modulated oxidative stress-related proteins, suggesting a potential protective effect against oxidative damage. Moreover, metabolic analysis revealed a decrease in glycolytic activity, indicating a potential restoration of cellular bioenergetic homeostasis. Conclusions: These results provide preliminary evidence supporting the nutraceutical interest of rhubarb-derived EVs in counteracting oxidative stress, while further studies will be needed to confirm their biological relevance and therapeutic potential.
Open AccessRhubarb-Derived Extracellular Vesicles Mitigate Oxidative Stress and Metabolic Dysfunction in an Alzheimer’s Cellular Model
Background/Objectives: Extracellular vesicles derived from edible plants have emerged as bioactive nanostructures with potential therapeutic and nutraceutical properties and are currently being investigated as natural carriers for the treatment of oxidative stress-induced damage and oxidative stress-related diseases, including neurodegenerative disorders such as Alzheimer’s disease (AD). Recent studies suggest that PDEVs exhibit high stability within the gastrointestinal tract and selective tissue-targeting abilities, facilitating the efficient delivery of bioactive molecules. Methods: This study investigates the antioxidant effects of Rheum rhabarbarum-derived EVs by assessing the antioxidant activity through different in vitro assays and their effects on oxidative stress and energy metabolism in the cellular model of Alzheimer’s disease. Results: Rhubarb-derived EVs showed measurable antioxidant capacity in chemical assays and were non-toxic under the tested conditions. Treatment reduced intracellular ROS levels and modulated oxidative stress-related proteins, suggesting a potential protective effect against oxidative damage. Moreover, metabolic analysis revealed a decrease in glycolytic activity, indicating a potential restoration of cellular bioenergetic homeostasis. Conclusions: These results provide preliminary evidence supporting the nutraceutical interest of rhubarb-derived EVs in counteracting oxidative stress, while further studies will be needed to confirm their biological relevance and therapeutic potential.
- Open Access
- 5 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (11) , 1672
Nanovesicles from Rosa canina: A Treasure Trove of Antioxidant Potential for Oxidative Stress, Inflammation, and Gut Microbiota Modulation
Background/Objectives: Extracellular vesicles (EVs) have become key facilitators of communication between cells, significantly influencing various physiological functions. Although EVs originating from mammalian cells have been heavily researched for their therapeutic applications, there is a growing interest in extracellular vesicles derived from edible plants (PDEVs) because of their unique bioactive characteristics. These nanovesicles (NVs) exhibit remarkable biocompatibility, low immunogenicity, and the ability to overcome biological barriers, making them promising candidates for biomedical applications. This study aimed to evaluate the antioxidant and anti-inflammatory properties of NVs isolated from Rosa canina berries. Methods: Antioxidant activity was assessed through in vitro assays, confirming their ability to fight oxidative stress. Additionally, enzymatic inhibition tests were conducted to explore their potential role in regulating key metabolic pathways associated with inflammation and oxidative damage. The antioxidant and anti-inflammatory activity of Rosa canina NVs was further tested on a THP-1 cell-based inflammation model, demonstrating their ability to modulate the inflammatory response at the cellular level. Moreover, the impact of these NVs on gut microbiota was investigated to assess their protective effects on antibiotic-induced dysbiosis. Results: The results demonstrated their ability to modulate oxidative stress, regulate enzymatic pathways, reduce inflammation in THP-1 cells, and influence gut microbiota in a positive manner.
- 5 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (11) , 1672
Open AccessNanovesicles from Rosa canina: A Treasure Trove of Antioxidant Potential for Oxidative Stress, Inflammation, and Gut Microbiota Modulation
Background/Objectives: Extracellular vesicles (EVs) have become key facilitators of communication between cells, significantly influencing various physiological functions. Although EVs originating from mammalian cells have been heavily researched for their therapeutic applications, there is a growing interest in extracellular vesicles derived from edible plants (PDEVs) because of their unique bioactive characteristics. These nanovesicles (NVs) exhibit remarkable biocompatibility, low immunogenicity, and the ability to overcome biological barriers, making them promising candidates for biomedical applications. This study aimed to evaluate the antioxidant and anti-inflammatory properties of NVs isolated from Rosa canina berries. Methods: Antioxidant activity was assessed through in vitro assays, confirming their ability to fight oxidative stress. Additionally, enzymatic inhibition tests were conducted to explore their potential role in regulating key metabolic pathways associated with inflammation and oxidative damage. The antioxidant and anti-inflammatory activity of Rosa canina NVs was further tested on a THP-1 cell-based inflammation model, demonstrating their ability to modulate the inflammatory response at the cellular level. Moreover, the impact of these NVs on gut microbiota was investigated to assess their protective effects on antibiotic-induced dysbiosis. Results: The results demonstrated their ability to modulate oxidative stress, regulate enzymatic pathways, reduce inflammation in THP-1 cells, and influence gut microbiota in a positive manner.
- Open Access
- 15 October 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (10) , 1031
Green Solutions to a Growing Problem: Harnessing Plants for Antibiotic Removal from the Environment
Environmental dissemination of antibiotics is a pressing global challenge, driving ecological imbalances and the proliferation of antibiotic resistance genes (ARGs). Conventional treatment technologies often fail to fully eliminate these micropollutants or are cost-prohibitive for widespread use. In this context, phytoremediation—using plants and their associated microbiota to remove, transform, or immobilize contaminants—has emerged as an effective and promising, low-impact, and nature-based approach for mitigating antibiotic pollution in aquatic and terrestrial environments. This review provides a comprehensive synthesis of the physiological, biochemical, and ecological mechanisms by which plants interact with antibiotics, including phytoextraction, phytodegradation, rhizodegradation, and phytostabilization. This review prioritizes phytoremediation goals, with attention to high-performing aquatic (e.g., Lemna minor, Eichhornia crassipes, Phragmites australis) and terrestrial plants (e.g., Brassica juncea, Zea mays) and their ability to remediate major classes of antibiotics. This study highlights the role of rhizosphere microbes and engineered systems in phytoremediation, while noting challenges such as variable efficiency, phytotoxicity risks, limited knowledge of by-products, and environmental concerns with antibiotic degradation. Future perspectives include the integration of genetic engineering, microbiome optimization, and smart monitoring technologies to enhance system performance and scalability. Plant-based solutions thus represent a vital component of next-generation remediation strategies aimed at reducing antibiotic burdens in the environment and curbing the rise in antimicrobial resistance.
- 15 October 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (10) , 1031
Open AccessGreen Solutions to a Growing Problem: Harnessing Plants for Antibiotic Removal from the Environment
Environmental dissemination of antibiotics is a pressing global challenge, driving ecological imbalances and the proliferation of antibiotic resistance genes (ARGs). Conventional treatment technologies often fail to fully eliminate these micropollutants or are cost-prohibitive for widespread use. In this context, phytoremediation—using plants and their associated microbiota to remove, transform, or immobilize contaminants—has emerged as an effective and promising, low-impact, and nature-based approach for mitigating antibiotic pollution in aquatic and terrestrial environments. This review provides a comprehensive synthesis of the physiological, biochemical, and ecological mechanisms by which plants interact with antibiotics, including phytoextraction, phytodegradation, rhizodegradation, and phytostabilization. This review prioritizes phytoremediation goals, with attention to high-performing aquatic (e.g., Lemna minor, Eichhornia crassipes, Phragmites australis) and terrestrial plants (e.g., Brassica juncea, Zea mays) and their ability to remediate major classes of antibiotics. This study highlights the role of rhizosphere microbes and engineered systems in phytoremediation, while noting challenges such as variable efficiency, phytotoxicity risks, limited knowledge of by-products, and environmental concerns with antibiotic degradation. Future perspectives include the integration of genetic engineering, microbiome optimization, and smart monitoring technologies to enhance system performance and scalability. Plant-based solutions thus represent a vital component of next-generation remediation strategies aimed at reducing antibiotic burdens in the environment and curbing the rise in antimicrobial resistance.
- Open Access
- 12 September 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (9) , 1362
Therapeutic Potential of Bioactive Compounds in Edible Mushroom-Derived Extracellular Vesicles: Isolation and Characterization of EVs from Pleurotus eryngii
Background/Objectives: Over the past twenty years, there has been a rapid increase in studies aimed at comprehending how cells communicate with each other via Extracellular Vesicles (EVs), accompanied by a heightened interest in plant-derived extracellular vesicles due to their potential relevance in dietary supplementation and therapeutic applications. However, there is a limited amount of research on extracellular vesicles derived from mushrooms (MDEVs). Among edible mushrooms, Pleurotus eryngii is peculiar due to its flavor and interesting nutritional profiling. It also produces a wide array of secondary metabolites including biologically active compounds with many health-promoting benefits such as anticancer, antioxidant, antitumor, antiviral, antibacterial, antidiabetic, and anti-hypercholesteremic activities. The aim of this work has been to isolate EVs from the fruiting body and mycelium of P. eryngii in order to investigate their potential applications as nutraceuticals. Methods: MDEVs were isolated by differential and density gradient centrifugation, characterized by Nanoparticle Tracking Analysis (NTA), Scanning Electron Microscopy (SEM) and immunoblotting, and subjected to metabolomic and phenolic profiling. Their antioxidant potential was assessed through in vitro radical scavenging (DPPH, ABTS) and metal-reducing (CUPRAC, FRAP) assays. Results: The findings suggest that mycelium-derived EVs may represent a valuable source of high-quality MDEVs, which exhibited promising antioxidant properties in all assays conducted, particularly in radical scavenging assays. Conclusions: These results highlight the potential of P. eryngii mycelium-derived EVs as a novel natural source of bioactive compounds, paving the way for future applications in nutraceutical and therapeutic fields.
- 12 September 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (9) , 1362
Open AccessTherapeutic Potential of Bioactive Compounds in Edible Mushroom-Derived Extracellular Vesicles: Isolation and Characterization of EVs from Pleurotus eryngii
Background/Objectives: Over the past twenty years, there has been a rapid increase in studies aimed at comprehending how cells communicate with each other via Extracellular Vesicles (EVs), accompanied by a heightened interest in plant-derived extracellular vesicles due to their potential relevance in dietary supplementation and therapeutic applications. However, there is a limited amount of research on extracellular vesicles derived from mushrooms (MDEVs). Among edible mushrooms, Pleurotus eryngii is peculiar due to its flavor and interesting nutritional profiling. It also produces a wide array of secondary metabolites including biologically active compounds with many health-promoting benefits such as anticancer, antioxidant, antitumor, antiviral, antibacterial, antidiabetic, and anti-hypercholesteremic activities. The aim of this work has been to isolate EVs from the fruiting body and mycelium of P. eryngii in order to investigate their potential applications as nutraceuticals. Methods: MDEVs were isolated by differential and density gradient centrifugation, characterized by Nanoparticle Tracking Analysis (NTA), Scanning Electron Microscopy (SEM) and immunoblotting, and subjected to metabolomic and phenolic profiling. Their antioxidant potential was assessed through in vitro radical scavenging (DPPH, ABTS) and metal-reducing (CUPRAC, FRAP) assays. Results: The findings suggest that mycelium-derived EVs may represent a valuable source of high-quality MDEVs, which exhibited promising antioxidant properties in all assays conducted, particularly in radical scavenging assays. Conclusions: These results highlight the potential of P. eryngii mycelium-derived EVs as a novel natural source of bioactive compounds, paving the way for future applications in nutraceutical and therapeutic fields.
- Open Access
Multi-Omic Characterization of Epithelial–Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma
Epithelial–mesenchymal transition (EMT) is a key process in cancer progression and fibrogenesis. In this study, EMT was induced in Huh7 hepatocellular carcinoma cells via TGF-β1 treatment, and the resulting lipidomic and metabolomic alterations were characterized. Morphological changes and protein marker analyses confirmed the transition to a mesenchymal phenotype, with reduced E-cadherin and increased vimentin and N-cadherin expression. Lipidomic profiling revealed a dose-dependent reorganization of membrane lipids, with a pronounced increase in the levels of ceramides, cholesteryl esters, and lysophospholipids, consistent with alterations in membrane structure, potential cellular stress, and modulation of inflammatory pathways. Changes in the content of phospholipid classes, including phosphatidylethanolamines and phosphatidylserines, indicate possible variations in membrane dynamics and potentially point to modifications in mitochondrial function, cellular stress responses, and redox balance. Metabolomic analysis further indicates an alteration of choline and phosphatidylcholine metabolism, consistent with a shift from de novo membrane synthesis toward lipid turnover. Reduced glycolytic capacity and modified acylcarnitine levels indicated impaired metabolic flexibility and mitochondrial efficiency. The integration of phenotypic, lipidomic, and metabolomic data suggests that TGF-β1 induces EMT and drives a coordinated metabolic reprogramming. These findings highlight the involvement of lipid and energy metabolism in sustaining EMT and suggest that specific metabolic reprogramming events characterize the mesenchymal shift in hepatocellular carcinoma. By exploring this process in a tumor-specific context, we aim to deepen our understanding of EMT complexity and its implications for tumor progression and therapeutic vulnerability.
Open AccessMulti-Omic Characterization of Epithelial–Mesenchymal Transition: Lipidomic and Metabolomic Profiles as Key Markers of TGF-β-Induced Transition in Huh7 Hepatocellular Carcinoma
Epithelial–mesenchymal transition (EMT) is a key process in cancer progression and fibrogenesis. In this study, EMT was induced in Huh7 hepatocellular carcinoma cells via TGF-β1 treatment, and the resulting lipidomic and metabolomic alterations were characterized. Morphological changes and protein marker analyses confirmed the transition to a mesenchymal phenotype, with reduced E-cadherin and increased vimentin and N-cadherin expression. Lipidomic profiling revealed a dose-dependent reorganization of membrane lipids, with a pronounced increase in the levels of ceramides, cholesteryl esters, and lysophospholipids, consistent with alterations in membrane structure, potential cellular stress, and modulation of inflammatory pathways. Changes in the content of phospholipid classes, including phosphatidylethanolamines and phosphatidylserines, indicate possible variations in membrane dynamics and potentially point to modifications in mitochondrial function, cellular stress responses, and redox balance. Metabolomic analysis further indicates an alteration of choline and phosphatidylcholine metabolism, consistent with a shift from de novo membrane synthesis toward lipid turnover. Reduced glycolytic capacity and modified acylcarnitine levels indicated impaired metabolic flexibility and mitochondrial efficiency. The integration of phenotypic, lipidomic, and metabolomic data suggests that TGF-β1 induces EMT and drives a coordinated metabolic reprogramming. These findings highlight the involvement of lipid and energy metabolism in sustaining EMT and suggest that specific metabolic reprogramming events characterize the mesenchymal shift in hepatocellular carcinoma. By exploring this process in a tumor-specific context, we aim to deepen our understanding of EMT complexity and its implications for tumor progression and therapeutic vulnerability.